Phone Intervention Decreases ED Visits, Hospitalizations in Head and Neck Cancer
A phone intervention can decrease ED visits and hospital admissions in head and neck cancer patients receiving radiation therapy, a study suggests.
A phone intervention can decrease ED visits and hospital admissions in head and neck cancer patients receiving radiation therapy, a study suggests.
During end-of-life care, cancer patients who utilized spiritual, psychology, and social work services received different oncologic treatment.
Adding motixafortide to G-CSF increases mobilization of CD34+ HSPCs in patients with multiple myeloma, a phase 3 trial suggests.
Combining camonsertib with PARP inhibitors may be an effective strategy for treating advanced solid tumors, a study suggests.
ALLO-316 has shown activity in a phase 1 study of patients with heavily pretreated, advanced clear cell renal cell carcinoma.
Petosemtamab can produce durable responses in patients with advanced head and neck squamous cell carcinoma, a phase 1/2 study suggests.
REGN5459 appears safe and can produce durable responses in patients with relapsed or refractory multiple myeloma, a phase 1/2 study suggests.
A prehabilitation intervention prior to colorectal cancer surgery decreased postoperative complication rates.
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it, a study suggests.
NCCN classification is associated with long-term outcomes in patients with localized prostate cancer, a new study suggests.